Haemonetics Corporation
HAE
$57.17
$0.280.49%
NYSE
| 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 10.83% | -11.84% | 88.41% | -34.81% | 25.43% |
| Total Depreciation and Amortization | -0.66% | 0.28% | 53.03% | -19.09% | 1.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.14% | 226.42% | -557.54% | -77.03% | -40.02% |
| Change in Net Operating Assets | -2.35% | 63.87% | -755.72% | 118.78% | -313.09% |
| Cash from Operations | -10.36% | 278.05% | -142.79% | 11,966.85% | -100.54% |
| Capital Expenditure | -20.58% | -21.37% | -1.88% | 56.56% | 9.57% |
| Sale of Property, Plant, and Equipment | 32.80% | -99.07% | 3,595.46% | 63.02% | -34.87% |
| Cash Acquisitions | 100.00% | 98.82% | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 67.62% | -1,716.08% | 90.02% | -73.28% | -212.90% |
| Cash from Investing | 25.66% | 83.21% | -966.15% | 95.15% | -969.97% |
| Total Debt Issued | -- | -100.00% | -- | -100.00% | -- |
| Total Debt Repaid | -- | 100.00% | -825.61% | -1,714.29% | 0.00% |
| Issuance of Common Stock | 1,310.36% | -94.30% | 4,052.83% | -96.37% | 321.68% |
| Repurchase of Common Stock | 99.40% | -669.68% | -- | 100.00% | 99.01% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,254.55% | 99.95% | -21,378.70% | -300.00% | 1,180.00% |
| Cash from Financing | 101.84% | -122.42% | 625.48% | -158.03% | 1,625.78% |
| Foreign Exchange rate Adjustments | -247.83% | 390.80% | 46.50% | -189.41% | 297.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.76% | -127.26% | 1,191.24% | 90.33% | -340.52% |